Analyst Price Target is $6.75
▲ +396.32% Upside Potential
This price target is based on 8 analysts offering 12 month price targets for Zymergen in the last 3 months. The average price target is $6.75, with a high forecast of $0.00 and a low forecast of $0.00. The average price target represents a 396.32% upside from the last price of $1.36.
Current Consensus is
Hold
The current consensus among 8 investment analysts is to hold stock in Zymergen.
Zymergen Inc. design, develop, and commercialize microbes, molecules, and materials. It offers an automation solution comprising reconfigurable automation carts, a modular hardware building blocks that allow for assembly of work cells customized for the particular needs of a lab; and automation control software, a cloud-based software used to control integrated automation systems. It serves electronics, packaging, healthcare, agriculture, and other industries. Zymergen Inc. was incorporated in 2013 and is based in Emeryville, California.
Read More